The cellular mode of action of the anti-epileptic drug 5,5-diphenylhydantoin.
D000818:Animals; D001001:Anura; D001369:Axons / Q000187:drug effects*; D001692:Biological Transport / Q000187:drug effects; D002463:Cell Membrane Permeability / Q000187:drug effects*; D049832:Decapodiformes; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects; D009132:Muscles / Q000187:drug effects*; D010672:Phenytoin / Q000494:pharmacology*; D011188:Potassium / Q000378:metabolism; D011894:Rana pipiens; D012964:Sodium / Q000378:metabolism*; D013779:Tetrodotoxin / Q000494:pharmacology; D014701:Veratridine / Q000494:pharmacology
D013779:Tetrodotoxin; D010672:Phenytoin; D014701:Veratridine; D012964:Sodium; D011188:Potassium